A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2002
11/21/2002	CA2445366A1 Molecules for disease detection and treatment
11/21/2002	CA2445003A1 Diarylurea derivatives useful as anti-inflammatory agents
11/20/2002	WO2001090252A1 Gelling composition
11/20/2002	EP1258481A1 Enaminotriazines as UV filters
11/20/2002	EP1258252A1 Integrin expression inhibitors
11/20/2002	EP1257646A2 Transporters and ion channels
11/20/2002	EP1257645A2 Fibroblast growth factor-23 molecules and uses thereof
11/20/2002	EP1257585A2 Antibodies that bind human interleukin-18 and methods of making and using
11/20/2002	EP1257583A2 METHODS FOR THE PREVENTION AND TREATMENT OF INFECTIONS USING ANTI-C3b(i) ANTIBODIES
11/20/2002	EP1257578A2 Transporters and ion channels
11/20/2002	EP1257563A1 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders
11/20/2002	EP1257556A1 Thiazolopyrimidines and their use as modulators of chemokine receptor activity
11/20/2002	EP1257555A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
11/20/2002	EP1257548A1 Benzofuran carboxamides and their therapeutic use
11/20/2002	EP1257546A1 Kinase inhibitors
11/20/2002	EP1257543A1 Pyridinylimidazoles
11/20/2002	EP1257536A1 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/20/2002	EP1257526A1 Aniline-derived ligands for the thyroid receptor
11/20/2002	EP1257304A1 Foam-forming wound dressing
11/20/2002	EP1257298A1 Cosmid dna constructs and methods of making and using the same
11/20/2002	EP1257281A1 Nucleoside analogs with carboxamidine modified monocyclic base
11/20/2002	EP1257280A1 Drospirenone for hormone replacement therapy
11/20/2002	EP1257272A1 Thiazolium compounds and treatments of disorders associated with protein aging
11/20/2002	EP1257270A1 A method for synthesizing leflunomide
11/20/2002	EP1257262A2 Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof
11/20/2002	EP1257253A2 Cosmetic preparations containing plant extracts
11/20/2002	EP1147101B1 Reverse hydroxamate inhibitors of matrix metalloproteinases
11/20/2002	EP0936897B1 Composition having tanning and sun-screening activity, and cosmetic uses thereof
11/20/2002	EP0929530B1 Quinazoline derivatives and pharmaceutical compositions containing them
11/20/2002	EP0912568B1 imidazopyridines
11/20/2002	EP0845992B1 Use of relaxin for promoting angiogenesis
11/20/2002	EP0831851B1 Use of pseudopterosins for promoting wound healing
11/20/2002	CN1380813A Primary composition containing lipophilic bioactive compound
11/20/2002	CN1380288A Tetrahydroisoquinoline hydroximic acid sulfamide compound, its synthesis method and its application
11/20/2002	CN1380279A (4-alkynyl), aromatic keto-acid compound, synthesis method and its application
11/20/2002	CN1380091A Medicine for curing cold injury made of natural plant raw material and its preparation method
11/20/2002	CN1380086A Ointment for curing wound and its production method
11/20/2002	CN1380085A Compound thunder god vine preparation for external application
11/20/2002	CN1380075A Cell repair
11/20/2002	CN1380069A Medicine for curing burn and scald and its preparation method
11/20/2002	CN1380063A Method for preventing and curing skid aging
11/20/2002	CN1380060A Solution type spray of antimycotic medicine for external application and its preparation method
11/20/2002	CN1094373C Medicine for curing pernio and its preparing method
11/20/2002	CN1094368C Chinese medicine for curing alopecia
11/20/2002	CN1094367C External-use medicine for curing skin disease, venereal disease and gynaopathy
11/20/2002	CN1094366C Ointment for curing burn and scald and its preparing process
11/20/2002	CN1094361C Composition comprising propolis and essential oil
11/20/2002	CN1094360C Fumigation roll for treating scald
11/20/2002	CN1094351C External-use medicine 'Gujiasan' powder and its preparing method
11/20/2002	CN1094344C Skin-protecting Chinese medicine
11/20/2002	CN1094342C Cosmetic preparation with peptide addition
11/20/2002	CA2410038A1 Gelling composition
11/19/2002	US6482848 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
11/19/2002	US6482842 3-aminopyrazole inhibitors of cyclin dependent kinases
11/19/2002	US6482839 Pyridine-thiols for treatment of a follicular dermatosis
11/19/2002	US6482834 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
11/19/2002	US6482830 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
11/19/2002	US6482822 N-(iminomethyl)amines derivatives, their preparation, their use as medicines and compositions containing them
11/19/2002	US6482812 Method of locking 1α-OH of vitamin D compounds in axial orientation
11/19/2002	US6482798 Aprotinin variants having a net charge of +3 to -3 at ph 7 and with the amino acids arg15 or arg15-ala17 in the binding region; serine protease inhibitor
11/19/2002	US6482624 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/19/2002	US6482446 Viscous and low alcohol content; be used for delivering
11/19/2002	US6482442 Substance mixture for topical application comprising olive oil and honey
11/19/2002	CA2154432C Cosmetic and/or dermatologic composition containing thermal or mineral water and an anti-acne and anti-aging active ingredient
11/19/2002	CA2153546C Periwinkle grain extract and composition containing the same
11/18/2002	CA2381637A1 Compositions and methods for treating or preventing convulsions or seizures
11/14/2002	WO2002090934A2 Evaluation of ultraviolet radiation damage to skin using new genemarkers, methods and compositions related thereto
11/14/2002	WO2002090600A2 A method for regulating immune function in primates using the foxp3 protein
11/14/2002	WO2002090553A2 Recombinant fusion proteins and the trimers thereof
11/14/2002	WO2002090552A2 Use of 2'-5'-oligoadenylate synthetase and/or rnasel or nucleic acids encoding them for diagnosis, prophylaxis or treatment of wound healing
11/14/2002	WO2002090530A2 Kinases and phosphatases
11/14/2002	WO2002090361A1 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
11/14/2002	WO2002090353A1 Sulfonamides
11/14/2002	WO2002090352A2 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3
11/14/2002	WO2002090349A1 N-oxide anthranylamide derivatives and their use as medicaments
11/14/2002	WO2002090332A2 Novel aeylheteroalkylaminε derivatives
11/14/2002	WO2002090330A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
11/14/2002	WO2002090326A1 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists
11/14/2002	WO2002090325A2 Benzazepinone alpha v integrin receptor antagonists
11/14/2002	WO2002090317A1 Substituted cyclohexane-1,4-diamine derivatives
11/14/2002	WO2002089917A2 Dermatological formulations
11/14/2002	WO2002089854A1 Gene transfer of angiogenic factor for skin disease
11/14/2002	WO2002089852A1 Soluble protein-polymer systems for drug delivery
11/14/2002	WO2002089806A1 Heterobicycles fkbp-ligands
11/14/2002	WO2002089802A2 Use of neurokinin receptor antagonists to treat androgen-dependent diseases
11/14/2002	WO2002089791A2 Acne treatment with lipooxigenase inhibitors
11/14/2002	WO2002089787A1 Potentiation of therapeutic effects of fatty acids
11/14/2002	WO2002089783A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties
11/14/2002	WO2002089743A2 Use of compositions for treating rosacea
11/14/2002	WO2002089581A1 Antimicrobial compounds and methods for their use
11/14/2002	WO2002069963A3 Compositions comprising ferulic acid, caffeic acid, tannic acid or ellagic acid and their use for the preparation of a medicament for the treatment of dermatological disorders
11/14/2002	WO2002062373A3 Tripeptides and tripeptide derivatives for the treatment of postlesional diseases of the nervous system
11/14/2002	WO2002049634A3 Dissociated glucocorticoid receptor antagonists for the treatment of clucocorticoid associated side-effect
11/14/2002	WO2002030385A3 Anti-inflammatory active ingredients
11/14/2002	WO2002018623A3 Methods and reagents for protease inhibition
11/14/2002	US20020169336 Able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders
11/14/2002	US20020169215 Treatment of a disease that is mediated by the expression or suppression of a redox sensitive gene, for example MCP-1, IL-6 and thrombin receptor; antiinflammatory agents; cardio-vascular disorders; atherosclerosis; immunology
11/14/2002	US20020169209 Potentiation of therapeutic effects of fatty acids
11/14/2002	US20020169203 Modulators of all three classes of calcium channel blocker subtypes (Small, Intermediate and Big conductance K channel (SK, IK and BK)) comprising malonate esters and nitriles; respiratory, brain, cardiovascular, urogenital disorders
11/14/2002	US20020169177 Imidazole and benzimidazole caspase inhibitors and uses thereof

1 ... 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 ... 1065